首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >UPLC-Q-TOF/MS-based metabolic profiling comparison of four major bioactive components in normal and CKD rat plasma, urine and feces following oral administration of Cornus officinalis Sieb and Rehmannia glutinosa Libosch herb couple extract
【24h】

UPLC-Q-TOF/MS-based metabolic profiling comparison of four major bioactive components in normal and CKD rat plasma, urine and feces following oral administration of Cornus officinalis Sieb and Rehmannia glutinosa Libosch herb couple extract

机译:基于UPLC-Q-TOF / MS的新代谢分析在正常和CKD大鼠血浆中的四个主要生物活性成分,尿液和粪便在口服癌症后癌症和REHMANNIA GLUTINOSA LIBOSCH草本夫妇提取物

获取原文
获取原文并翻译 | 示例
           

摘要

Cornus officinalis-Rehmannia glutinosa herb couple is widely used herb medicine in clinical practice to treat chronic kidney disease (CKD). However, the in vivo integrated metabolism of its main bioactive components in CKD rats remains unknown. In this study, UPLC-Q-TOF/MS technique combined with Metabolynx (TM) software, was developed and successfully applied for analysis of metabolic profiles of the bioactive components of the herb couple in normal and CKD rat biological samples. Main parent components of the herb couple extract such as loganin, morroniside and catalpol were absorbed into the blood circulation of the normal and CKD rats. Another parent component acteoside was almost completely degraded. Seventeen metabolites involved in the in vivo metabolism processes were tentatively identified. These metabolites indicated that loganin was mainly metabolized to the demethylated product, and morroniside was firstly deglycosylated to the aglycone and the latter was subsequently demethylated and acetylated. Additionally, hydrogenation and deglycosylation were the principal metabolic reactions of catalpol; while O-glucuronide and O-sulphate conjugates were observed as major metabolites for methylated caffeic acid and hydroxytyrosol released from acteoside. Compared with the normal group, the CKD rat showed lower conversion capability. Few kinds and minor amounts of the metabolites appeared in the CKD rat samples. While considerable amounts of the parent compounds were detected in the CKD plasma. This will help maintain a high blood drug concentration which might be beneficial for the treatment of CKD. The proposed method could develop an integrated template approach to analyze screening and identification of the bioactive components in plasma, urine and feces after oral administration of herb medicines. Additionally, this investigation might provide helpful chemical information for further pharmacology and active mechanism research on herb medicines. (C) 2018 Published by Elsevier B.V.
机译:Cornus Officinalis-Rehmannia谷氨酸草药夫妇在临床实践中广泛使用了草药治疗慢性肾病(CKD)。然而,CKD大鼠主要生物活性成分的体内综合代谢仍然未知。在该研究中,开发并成功地开发了UPLC-Q-TOF / MS技术与Metabolynx(TM)软件一起开发并成功地应用于正常和CKD大鼠生物样品中草本植物的生物活性成分的代谢谱。草本植物的主要母体组分如Loganin,Morroniside和Catalpol等草药提取物被吸收到正常和CKD大鼠的血液循环中。另一种母体组分尸体几乎完全降低。暂时鉴定了参与体内代谢过程中的十七种代谢物。这些代谢物表明,Loganin主要被代谢到去甲基化产物中,并且将莫罗基酰胺首先将其含有糖苷化的糖苷化,后者随后去甲基化并乙酰化。另外,氢化和脱糖基化是催化剂的主要代谢反应;虽然O-葡糖醛酸酯和O-硫酸盐缀合物被观察为甲基化咖啡酸和羟基羟基醇的主要代谢产物,释放出致动己酯。与正常组相比,CKD大鼠表现出较低的转化能力。 CKD大鼠样品中出现了几种种类和少量的代谢物。虽然在CKD血浆中检测到大量的母体化合物。这将有助于保持高血药物浓度,这可能有利于治疗CKD。该方法可以开发一种综合模板方法,分析口服药草口服血浆,尿液和粪便中生物活性成分的筛选和鉴定。此外,该调查可能为草药药物的进一步药理和积极机制研究提供有用的化学信息。 (c)2018由elestvier b.v出版。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号